https://www.cancernetwork.com/view/pembrolizumab-plus-chemo-improves-pfs-in-pd-l1-hr-her2-breast-cancer2026-10-28T21:00:00Z2026-10-28T21:00:00Z https://www.cancernetwork.com/view/cea-high-expression-shows-early-promise-as-a-biomarker-for-bg-c477-in-nsclc2026-10-28T20:00:00Z2026-10-28T20:00:00Z https://www.cancernetwork.com/view/new-astro-guideline-backs-hypofractionated-radiation-in-prostate-cancer2026-10-28T19:00:00Z2026-10-28T19:00:00Z https://www.cancernetwork.com/view/cemiplimab-data-from-empower-cscc-1-and-c-post-reshape-advanced-cscc-care2026-10-28T18:11:55.095Z2026-10-28T18:11:55.095Z https://www.cancernetwork.com/view/futibatinib-pemigatinib-lirafugratinib-yield-similar-pfs-in-fgfr-altered-biliary-tract-cancers2026-10-28T18:00:00Z2026-10-28T18:00:00Z https://www.cancernetwork.com/view/a-pilot-trial-of-n-803-patients-with-synovial-sarcoma-and-myxoid-round-cell-liposarcoma-previously-treated-with-adoptive-cellular-therapy2026-10-28T17:20:49.566Z2026-10-28T17:20:49.566Z https://www.cancernetwork.com/view/the-next-frontier-of-cellular-therapy-in-oncology2026-10-28T17:00:54.468Z2026-10-28T17:00:54.468Z https://www.cancernetwork.com/view/iza-bren-plus-pembrolizumab-shows-activity-in-recurrent-or-metastatic-hnscc2026-10-28T17:00:00Z2026-10-28T17:00:00Z https://www.cancernetwork.com/view/data-support-real-world-benefit-of-cemiplimab-in-advanced-nsclc-care2026-10-28T16:00:00Z2026-10-28T16:00:00Z https://www.cancernetwork.com/view/sac-tmt-combo-improves-pfs-in-first-line-pd-l1-negative-nonsquamous-nsclc2026-10-28T15:00:00Z2026-10-28T15:00:00Z https://www.cancernetwork.com/view/melanoma-and-skin-cancer-data-you-may-have-missed-at-esmo-20262026-10-28T14:00:00Z2026-10-28T14:00:00Z https://www.cancernetwork.com/view/cardiac-assessment-with-atrial-fibrillation-and-closing-thoughts2026-10-28T12:05:00Z2026-10-28T12:05:00Z https://www.cancernetwork.com/view/counseling-on-dose-delays-and-reductions-and-extending-the-dosing-interval2026-10-28T12:05:00Z2026-10-28T12:05:00Z https://www.cancernetwork.com/view/counseling-before-treatment-and-interpreting-a-new-corneal-finding-in-a-responding-patient2026-10-28T12:00:00Z2026-10-28T12:00:00Z https://www.cancernetwork.com/view/top-poster-takeaways-for-urothelial-carcinoma-from-the-2026-esmo-congress2026-10-28T12:00:00Z2026-10-28T12:00:00Z https://www.cancernetwork.com/view/combination-therapy-vs-monotherapy-in-egfr-mutated-nsclc2026-10-28T12:00:00Z2026-10-28T12:00:00Z https://www.cancernetwork.com/view/clinical-scenario-2-discussion-of-treatment-goals-augment-101-and-antifungal-selection-in-relapsed-kmt2a-rearranged-aml2026-10-28T12:00:00Z2026-10-28T12:00:00Z https://www.cancernetwork.com/view/prior-ici-exposure-linked-to-higher-dermatitis-risk-with-lirafugratinib-in-fgfr2-altered-tumors2026-10-27T20:00:00Z2026-10-27T20:00:00Z https://www.cancernetwork.com/view/encorafenib-binimetinib-plus-pembrolizumab-extends-pfs-in-braf-v600-melanoma2026-10-27T19:00:00Z2026-10-27T19:00:00Z https://www.cancernetwork.com/view/real-world-data-on-cemiplimab-monotherapy-align-with-prior-nsclc-studies2026-10-27T18:00:00Z2026-10-27T18:00:00Z https://www.cancernetwork.com/view/cisplatin-free-pembrolizumab-regimen-misses-primary-end-point-in-smart-key2026-10-27T17:00:00Z2026-10-27T17:00:00Z https://www.cancernetwork.com/view/fda-receives-bla-for-etentamig-in-relapsed-refractory-multiple-myeloma2026-10-27T16:30:00Z2026-10-27T16:30:00Z https://www.cancernetwork.com/view/risvutatug-rezetecan-improves-pfs-in-relapsed-refractory-osteosarcoma2026-10-27T16:00:00Z2026-10-27T16:00:00Z https://www.cancernetwork.com/view/pimicotinib-responses-deepen-over-2-years-in-tenosynovial-giant-cell-tumor2026-10-27T15:00:00Z2026-10-27T15:00:00Z https://www.cancernetwork.com/view/elranatamab-improves-pfs-vs-standard-regimens-in-r-r-multiple-myeloma2026-10-27T14:30:00Z2026-10-27T14:30:00Z https://www.cancernetwork.com/view/sharing-responsibility-to-increase-representation-in-cancer-clinical-trials2026-10-27T14:00:00Z2026-10-27T14:00:00Z https://www.cancernetwork.com/view/novel-sez6-directed-adc-shows-robust-activity-in-relapsed-refractory-sclc2026-10-27T13:00:00Z2026-10-27T13:00:00Z https://www.cancernetwork.com/view/cemiplimab-shows-real-world-efficacy-in-advanced-nsclc-study2026-10-26T21:00:00Z2026-10-26T21:00:00Z https://www.cancernetwork.com/view/integrating-functional-testing-and-genomic-profiling-to-guide-cancer-treatment2026-10-26T20:00:00Z2026-10-26T20:00:00Z https://www.cancernetwork.com/view/pembrolizumab-improves-pfs-over-chemo-in-dmmr-endometrial-cancer2026-10-26T19:27:48.342Z2026-10-26T19:27:48.342Z https://www.cancernetwork.com/view/calderasib-regimen-shows-meaningful-responses-in-frontline-kras-g12c-nsclc2026-10-26T19:00:00Z2026-10-26T19:00:00Z https://www.cancernetwork.com/view/sac-tmt-improves-survival-vs-chemotherapy-in-pretreated-endometrial-cancer2026-10-26T18:21:53.064Z2026-10-26T18:21:53.064Z https://www.cancernetwork.com/view/could-oral-vitamin-c-confer-os-benefit-in-ccus-and-lower-risk-mds-2026-10-26T18:00:00Z2026-10-26T18:00:00Z https://www.cancernetwork.com/view/ctdna-clearance-tracks-with-survival-on-pembrolizumab-in-hpv-negative-hnscc2026-10-26T17:00:00Z2026-10-26T17:00:00Z https://www.cancernetwork.com/view/fda-approves-talazoparib-enzalutamide-for-hrr-gene-altered-metastatic-prostate-cancer2026-10-26T16:50:44.694Z2026-10-26T16:50:44.694Z https://www.cancernetwork.com/view/pumitamig-combo-yields-activity-in-metastatic-non-small-cell-lung-cancer2026-10-26T16:00:00Z2026-10-26T16:00:00Z https://www.cancernetwork.com/view/dostarlimab-yields-sustained-ccrs-in-dmmr-msi-h-locally-advanced-rectal-cancer2026-10-26T15:30:00Z2026-10-26T15:30:00Z https://www.cancernetwork.com/view/omitting-rt-after-lumpectomy-yields-14-8-5-year-local-recurrence-in-older-women2026-10-26T15:00:00Z2026-10-26T15:00:00Z https://www.cancernetwork.com/view/matching-first-line-combinations-to-disease-pace-and-burden2026-10-26T12:15:00Z2026-10-26T12:15:00Z https://www.cancernetwork.com/view/individualizing-treatment-in-multiple-myeloma2026-10-26T12:05:00Z2026-10-26T12:05:00Z https://www.cancernetwork.com/view/local-therapy-and-tp53-in-a-high-risk-first-line-decision2026-10-26T12:05:00Z2026-10-26T12:05:00Z https://www.cancernetwork.com/view/exploring-the-use-of-glp-1-receptor-agonists-in-breast-cancer-care2026-10-26T12:00:00Z2026-10-26T12:00:00Z https://www.cancernetwork.com/view/pfs-mrd-and-treatment-duration-in-multiple-myeloma2026-10-26T12:00:00Z2026-10-26T12:00:00Z https://www.cancernetwork.com/view/case-1-brain-metastases-and-tp53-co-mutation2026-10-26T12:00:00Z2026-10-26T12:00:00Z https://www.cancernetwork.com/view/selecting-first-line-therapy-in-advanced-rcc2026-10-26T12:00:00Z2026-10-26T12:00:00Z https://www.cancernetwork.com/view/ivonescimab-combo-improves-survival-in-advanced-biliary-tract-cancer2026-10-25T19:00:00Z2026-10-25T19:00:00Z https://www.cancernetwork.com/view/osimertinib-savolitinib-improves-survival-in-met-altered-egfr-mutant-nsclc2026-10-25T18:30:00Z2026-10-25T18:30:00Z https://www.cancernetwork.com/view/how-can-functional-modeling-ai-accelerate-translational-breast-cancer-research-2026-10-25T18:00:00Z2026-10-25T18:00:00Z https://www.cancernetwork.com/view/sonesitatug-vedotin-improves-os-in-pretreated-cldn18-2-gastroesophageal-cancer2026-10-25T17:30:00Z2026-10-25T17:30:00Z https://www.cancernetwork.com/view/divarasib-improves-survival-vs-sotorasib-or-adagrasib-in-kras-g12c-nsclc2026-10-25T17:22:39.258Z2026-10-25T17:22:39.258Z https://www.cancernetwork.com/view/top-takeaways-for-renal-cell-carcinoma-from-the-2026-esmo-congress2026-10-25T16:00:00Z2026-10-25T16:00:00Z https://www.cancernetwork.com/view/abiraterone-shows-durable-survival-benefit-in-de-novo-metastatic-cspc2026-10-25T13:00:00Z2026-10-25T13:00:00Z https://www.cancernetwork.com/view/apalutamide-adt-improves-efs-vs-surgery-alone-in-high-risk-prostate-cancer2026-10-24T19:00:00Z2026-10-24T19:00:00Z https://www.cancernetwork.com/view/tarlatamab-maintenance-combo-extends-survival-in-extensive-stage-sclc2026-10-24T16:30:00Z2026-10-24T16:30:00Z https://www.cancernetwork.com/view/interpath-001-data-detail-survival-subgroup-and-safety-findings-in-melanoma2026-10-24T15:36:44.839Z2026-10-24T15:36:44.839Z https://www.cancernetwork.com/view/belantamab-mafodotin-combo-yields-high-mrd-negativity-in-ndmm2026-10-24T15:00:00Z2026-10-24T15:00:00Z https://www.cancernetwork.com/view/narrowing-breast-cancer-disparities-through-collaborative-research-and-trial-representation2026-10-24T14:00:00Z2026-10-24T14:00:00Z https://www.cancernetwork.com/view/emactuzumab-yields-improved-response-rates-in-tenosynovial-giant-cell-tumor2026-10-24T13:27:45.732Z2026-10-24T13:27:45.732Z https://www.cancernetwork.com/view/ctdna-is-prognostic-regardless-of-therapy-in-cisplatin-eligible-mibc2026-10-23T22:00:00Z2026-10-23T22:00:00Z https://www.cancernetwork.com/view/daraxonrasib-demonstrates-consistent-survival-across-subgroups-in-pretreated-mpdac2026-10-23T21:03:55.603Z2026-10-23T21:03:55.603Z https://www.cancernetwork.com/view/pembrolizumab-plus-chemo-shows-encouraging-activity-in-nepc2026-10-23T20:00:00Z2026-10-23T20:00:00Z https://www.cancernetwork.com/view/top-poster-takeaways-for-prostate-cancer-from-2026-esmo-congress2026-10-23T19:00:00Z2026-10-23T19:00:00Z https://www.cancernetwork.com/view/adjuvant-ribociclib-improves-os-at-6-years-in-hr-her2--early-breast-cancer2026-10-23T17:00:00Z2026-10-23T17:00:00Z https://www.cancernetwork.com/view/extended-letrozole-sustains-dfs-benefit-at-15-years-in-hr-breast-cancer2026-10-23T14:30:00Z2026-10-23T14:30:00Z https://www.cancernetwork.com/view/perioperative-pembrolizumab-plus-chemo-does-not-significantly-improve-efs-in-mibc2026-10-23T13:45:00Z2026-10-23T13:45:00Z https://www.cancernetwork.com/view/sacituzumab-or-dato-dxd-experts-weigh-first-line-adcs-in-metastatic-tnbc2026-10-23T12:00:00Z2026-10-23T12:00:00Z https://www.cancernetwork.com/view/what-pope-leo-xiv-s-lung-cancer-diagnosis-could-mean-for-stigma-nihilism2026-10-23T00:00:00Z2026-10-23T00:00:00Z https://www.cancernetwork.com/view/zipalertinib-may-introduce-another-option-to-egfr-exon-20-nsclc2026-10-22T21:00:00Z2026-10-22T21:00:00Z https://www.cancernetwork.com/view/intismeran-plus-pembrolizumab-reduces-recurrence-risk-in-resected-melanoma2026-10-22T20:27:40.811Z2026-10-22T20:27:40.811Z https://www.cancernetwork.com/view/rethinking-patient-selection-strategy-for-phase-1-breast-cancer-trials2026-10-22T20:00:00Z2026-10-22T20:00:00Z https://www.cancernetwork.com/view/fda-approves-pembrolizumab-in-metastatic-tmb-h-solid-tumors2026-10-22T19:09:09.077Z2026-10-22T19:09:09.077Z https://www.cancernetwork.com/view/what-is-the-case-for-earlier-car-t-cell-referral-in-multiple-myeloma-2026-10-22T17:00:00Z2026-10-22T17:00:00Z https://www.cancernetwork.com/view/esmo-2026-the-presentations-that-may-transform-the-lung-cancer-paradigm2026-10-22T17:00:00Z2026-10-22T17:00:00Z https://www.cancernetwork.com/view/fda-accepts-sonoclear-system-510-k-submission-for-brain-tumor-resection-imaging2026-10-22T16:00:00Z2026-10-22T16:00:00Z https://www.cancernetwork.com/view/disitamab-vedotin-combo-shows-efficacy-in-unresectable-erbb2-positive-nmibc2026-10-22T15:00:00Z2026-10-22T15:00:00Z https://www.cancernetwork.com/view/sunvozertinib-now-available-in-us-for-egfr-exon-20-nsclc2026-10-22T14:30:00Z2026-10-22T14:30:00Z https://www.cancernetwork.com/view/how-is-the-big-ten-crc-reshaping-early-phase-breast-cancer-trials-2026-10-22T14:00:00Z2026-10-22T14:00:00Z https://www.cancernetwork.com/view/from-keynote-b49-to-novel-adcs-breast-cancer-trials-to-watch-at-esmo-20262026-10-22T13:00:00Z2026-10-22T13:00:00Z https://www.cancernetwork.com/view/efficacy-interpretation-quality-of-life-and-dosing-flexibility-with-belantamab-mafodotin2026-10-22T12:00:00Z2026-10-22T12:00:00Z https://www.cancernetwork.com/view/which-head-and-neck-cancer-data-should-you-watch-for-at-esmo-2026-2026-10-21T22:00:00Z2026-10-21T22:00:00Z https://www.cancernetwork.com/view/reducing-stigma-and-nihilism-around-lung-cancer-screening-and-diagnosis2026-10-21T20:00:00Z2026-10-21T20:00:00Z https://www.cancernetwork.com/view/discussing-guidelines-new-data-and-earlier-referrals-in-multiple-myeloma2026-10-21T19:00:00Z2026-10-21T19:00:00Z https://www.cancernetwork.com/view/efficacy-and-safety-of-immune-checkpoint-inhibitors-combined-with-chemoradiotherapy-in-limited-stage-small-cell-lung-cancer2026-10-21T17:30:00Z2026-10-21T17:30:00Z https://www.cancernetwork.com/view/cosibelimab-now-nccn-category-2a-in-locally-advanced-cutaneous-squamous-cell-carcinoma2026-10-21T16:00:00Z2026-10-21T16:00:00Z https://www.cancernetwork.com/view/sofetabart-mipitecan-shows-activity-across-fr-expression-levels-in-proc2026-10-21T15:00:13.744Z2026-10-21T15:00:13.744Z https://www.cancernetwork.com/view/ec-expands-enfortumab-vedotin-pembrolizumab-approval-for-resectable-mibc2026-10-21T14:00:00Z2026-10-21T14:00:00Z https://www.cancernetwork.com/view/first-6-weeks-post-transplant-maintenance-and-co-mutations2026-10-21T12:05:00Z2026-10-21T12:05:00Z https://www.cancernetwork.com/view/impact-of-baseline-comorbidities-on-treatment-decisions2026-10-21T12:05:00Z2026-10-21T12:05:00Z https://www.cancernetwork.com/view/rash-dose-modifications-and-conclusions-at-extended-follow-up2026-10-21T12:05:00Z2026-10-21T12:05:00Z https://www.cancernetwork.com/view/extended-copernicus-follow-up-on-skin-toxicity-and-thrombosis2026-10-21T12:00:00Z2026-10-21T12:00:00Z https://www.cancernetwork.com/view/monitoring-and-treatment-selection-for-a-community-patient2026-10-21T12:00:00Z2026-10-21T12:00:00Z https://www.cancernetwork.com/view/clinical-scenario-for-choosing-a-menin-inhibitor-for-relapsed-npm1-mutated-aml2026-10-21T12:00:00Z2026-10-21T12:00:00Z https://www.cancernetwork.com/view/why-ai-needs-a-human-in-the-loop-for-lung-cancer-screening-decisions2026-10-21T12:00:00Z2026-10-21T12:00:00Z https://www.cancernetwork.com/view/monitoring-anemia-and-optimizing-regimen-selection-in-resectable-nsclc2026-10-20T22:00:00Z2026-10-20T22:00:00Z https://www.cancernetwork.com/view/the-gynecologic-oncology-data-to-watch-at-esmo-2026-de-escalation-and-adcs2026-10-20T21:00:00Z2026-10-20T21:00:00Z https://www.cancernetwork.com/view/treating-the-thyroid-as-an-organ-at-risk-in-supraclavicular-breast-irradiation2026-10-20T20:00:00Z2026-10-20T20:00:00Z https://www.cancernetwork.com/view/the-usefulness-of-indocyanine-green-in-cytoreductive-ovarian-cancer-surgery2026-10-20T17:45:00Z2026-10-20T17:45:00Z https://www.cancernetwork.com/view/cancer-vaccine-combinations-improve-1-year-survival-in-second-line-nsclc2026-10-20T16:00:00Z2026-10-20T16:00:00Z https://www.cancernetwork.com/view/trispecific-car-t-cells-demonstrate-safety-early-activity-in-b-cell-lymphoma2026-10-20T15:00:00Z2026-10-20T15:00:00Z https://www.cancernetwork.com/view/how-clinical-hypothyroidism-was-defined-in-a-proton-vs-photon-breast-rt-study2026-10-20T14:00:00Z2026-10-20T14:00:00Z